Introduction {#S5}
============

C-reactive protein (CRP) is a recognized part of the acute phase response and is associated with various inflammatory diseases \[[@R1]\]. It is also considered to be a marker both of inflammation as well as of cancer \[[@R2],[@R3]\]. Although it is secreted in the presence of HCC, it is not considered to be a diagnostic marker, but it has nevertheless been reported to have significant prognostic value \[[@R4]--[@R7]\]. The Glasgow inflammation score consisting of CRP and albumin, and has been shown to be an independent prognosticator for several cancer types, including HCC \[[@R8]--[@R17]\]. Furthermore, there is evidence that CRP is produced not just by hepatocytes, but also by HCC cells \[[@R18],[@R19]\]. More recently, several other indices of inflammation, in particular the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio have been also suggested to be useful HCC prognosticators \[[@R20]--[@R29]\]. In this paper, we compare in a large Turkish HCC cohort, the neutrophil-to-lymphocyte ratio, the platelet-to-lymphocyte ratio and the C-reactive protein values (part of the Glasgow Index) and examine the relationship of all 3 indices to parameters of HCC tumour aggressiveness, in an attempt to explain the prognostic usefulness of these inflammatory indices.

Methods {#S6}
=======

Patient data {#S7}
------------

In this study, we analysed a database of 424 patients prospectively-accrued HCC patients who had full baseline tumour parameter data, including CT scan information on HCC size, number of tumour nodules and presence or absence of PVT, plasma AFP levels, complete blood count and routine blood liver function tests. Diagnosis was made either through tumour biopsy or according to international guidelines. Database management conformed to legislation on privacy and this study conforms to the ethical guidelines of the Declaration of Helsinki and approval for this retrospective study on de-identified HCC patients was obtained by the Institutional Review Board of each participating institution \[[@R30]\].

Statistical analyses {#S8}
--------------------

The continuous variables including, maximum tumour diameter (MTD), alpha-fetoprotein (AFP) and CRP were divided into two groups with different cut-off values as less than 3 and ≥3, less than 20 and ≥20, and ≤10 and more than 10, respectively. Descriptive statistics for continuous variables, such as the neutrophils-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) for MTD, AFP, multifocality and portal vein thrombosis (PVT) groups were calculated with mean, standard deviation, median, interquartile range, minimum and maximum values. Shapiro-Wilk test was used to check the normality assumption of the continuous variables. In the cases of non-normally distributed data, the Wilcoxon rank-sum (Mann-Whitney U) test was performed to determine whether the difference between the two groups was statistically significant. A linear regression model was constructed to evaluate the associations between PLR on single variables. The univariate logistic regression method was utilized to assess the factors associated with CRP (≤10/\>10) and Glasgow index (\<2/=2) in single variables, and then multiple logistic regression method was performed. All final multiple logistic regression models were executed with the backward stepwise method. The ability of PLR, NLR and CRP values to predict MTD, AFP, Multifocality and PVT groups in HCC patients were examined by receiver operating characteristic (ROC) curve and their respective areas under the curve. A p-value of less than 0.05 was considered as statistically significant. All statistical analyses were performed using IBM SPSS version 21.0 (Chicago, IL, USA).

Results {#S9}
=======

Descriptive statistics of PLR, NLR and CRP in relation to tumour characteristics {#S10}
--------------------------------------------------------------------------------

The focus of this study was 424 HCC patients with full data including CRP levels. Mean PLR, NLR and CRP were 0.16±0.13, 4.53±4.66 and 18.44±33.24, respectively (data not shown) ([Table 1](#T1){ref-type="table"}). summarizes the descriptive statistics and comparisons of the NLR ratio, PLR ratio and CRP levels for each of the 4 tumour characteristics of MTD, AFP, multifocality and PVT patient groups. The PLR and the CRP in the MTD≥3cm group were statistically significantly higher than the MTD\<3cm group (p = 0.002 and p = 0.001, respectively). The CRP level, but not the NRL and PLR ratios in the AFP≥20 IU/ml group were found to be significantly increased compared to the AFP\<20 IU/ml group (p\<0.001). We also found that the PLR ratio and the CRP levels were significantly greater in the patients with presence of PVT compared with the PVT absent group (p = 0.034 and p\<0.001, respectively). Our statistical analysis indicates that NLR levels were not significantly different among MTD, AFP, multifocality or PVT groups (p\>0.05). However, when multifocality compared to unifocality, neither NLR nor CRP were significantly altered between the 2 groups, and the PLR was actually lower in the multifocal patients than the unifocal ones (p = 0.041).

Regression models on single variables and final models for tumour parameters {#S11}
----------------------------------------------------------------------------

Linear regression models were then constructed for the association between the PLR ratio and the four tumour parameters, separately ([Table 2A](#T2){ref-type="table"}). Based on our regression models ([Table 2A](#T2){ref-type="table"}), MTD was the only statistically significant parameter (p = 0.004). A univariate logistic regression models of the CRP groups (CRP≤10 and \>10) provided distinct p-values for each of the four tumour parameters, and MTD, AFP, and PVT were found to be statistically significant ([Table 2B](#T2){ref-type="table"}; p\<0.05). In the final model of the CRP groups ([Table 2D](#T2){ref-type="table"}), significant associations were also detected between CRP groups and MTD, AFP and PVT (p\<0.05). Similar results were obtained for univariate logistic regression models of Glasgow index, which is a composite of serum CRP plus serum albumin ([Table 3C and 3E](#T3){ref-type="table"}). All of the four tumour parameters were found to be statistically significant on single variable models for the Glasgow index ([Table 2C](#T2){ref-type="table"}), however only two of them (MTD and AFP) were statistically significant in the final model ([Table 2E](#T2){ref-type="table"}; p\<0.05).

Final models of logistic regression analysis for tumour characteristics {#S12}
-----------------------------------------------------------------------

Final models of logistic regression analysis for independent variables the PLR, NLR ratios and CRP/Glasgow index were then built to evaluate their associations with each of the four tumour parameters ([Table 3](#T3){ref-type="table"}). This analysis revealed that the PLR and CRP/Glasgow index were significantly associated with MTD ([Table 3A](#T3){ref-type="table"}; p\<0.05). In the models of AFP ([Table 3B](#T3){ref-type="table"}), only the CRP level and Glasgow index were significantly associated with the AFP (p\<0.05). We also found that the CRP level and Glasgow index were useful for predicting the absence or presence of PVT, as shown in ([Table 3D](#T3){ref-type="table"}). However, NLR was significant in the model with Glasgow index, but not in the model with CRP ([Table 3D](#T3){ref-type="table"}). Furthermore, there were no statistically significant variables for the model of multifocality ([Table 3C](#T3){ref-type="table"}; p\>0.05).

Receiver operating characteristic (ROC) curves for PLR, NLR and CRP {#S13}
-------------------------------------------------------------------

A ROC curve analysis was then performed ([Table 4](#T4){ref-type="table"}). Our results clearly indicated that AUC for the PLR and CRP was statistically significant for high versus low MTD and presence versus absence of PVT ([Table 4](#T4){ref-type="table"}). CRP alone was significant for high versus low AFP. Besides, the AUC values of the PLR, NLR and CRP were not statistically significant for multifocality (p\>0.05). ROC curves of PLR, NLR and CRP for four parameters are shown in ([Figure 1](#F1){ref-type="fig"}).

Discussion {#S14}
==========

In order to better understand their significance, we have examined the associations of 3 commonly used systemic inflammatory markers with each of 4 HCC tumour parameters that reflect HCC aggressiveness. The PLR ratio and the CRP level were each significantly higher in patients with high MTD and positive PVT. Higher CRP levels also significantly associated with higher AFP values. The calculated p-value for the comparison of PLR ratio between multifocal and unifocal patients was near the significance threshold (p\<0.05). We thus considered the significance of PLR as a marker to be inconclusive, until more patient data are obtained to accurately elucidate its significance in relation to tumour parameters. The NLR ratio was not found to be a significant marker among the 4 tumour parameters.

When the 4 tumour parameters were included separately in the linear regression model, MTD was the only parameter to predict PLR ([Table 2](#T2){ref-type="table"}). Our results suggest that patients with MTD≥3cm are almost 3 times more likely to have CRP\>10 and nearly twice as likely to have a Glasgow index (CRP plus albumin) = 2. Similarly, patients with AFP≥20 or positive PVT were almost twice as likely to have CRP\>10. In the final models of the 4 tumour parameters ([Table 3](#T3){ref-type="table"}), we found that the PLR and NLR ratios might have potential to predict MTD and PVT, respectively. Although, the PLR and NLR ratios were statistically significant, their corresponding p-values were near the threshold, and our data set might be insufficiently large to be used in making predictions. CRP was a significant variable for MTD, AFP and PVT, while Glasgow index was a significant variable for all the final models-MTD, AFP, PVT and multifocality. Thus, Glasgow index is likely to be a "one-size fits all" predictor for the all 4 tumour parameters. In summary, CRP/Glasgow index has more general use, but for MTD, PLR is far more sensitive a discriminator.

The results of AUC for the PLR ratio and CRP were statistically significant in the MTD and PVT groups. CRP alone was significant for high versus low AFP. In our results ([Table 4](#T4){ref-type="table"}), CRP had the highest AUC to classify the MTD, AFP and PVT groups.

CRP is a non-specific inflammatory marker that has long been recognized as associated with various inflammatory diseases including coronary artery disease and cancer \[[@R1],[@R3],[@R31]--[@R33]\]. Amongst cancers, it has been particularly related to survival amongst gastrointestinal and urothelial cancers, and more recently for HCC \[[@R5]--[@R10]\]. CRP is synthesized by hepatocytes, particularly under the control of IL-6, but also of IL-1 and TNF. HCC is particularly associated with inflammation in most cases, due to either chronic hepatitis B, chronic hepatitis C, alcoholism or metabolic syndrome. The development of HCC usually involves several stages, including fibrosis and cirrhosis, both of which are inflammation-associated \[[@R34]\]. The role of the inflammation has been subject to increasing speculation and some experimentation. Inflammation is thought to induce a microenvironment that is involved in DNA damage, tumour growth and angiogenesis. This appears to involve a 2-way process, in which inflammation can be seen as a response to growing tumour cells and also is involved in their growth and invasiveness \[[@R33],[@R35]\]. Various mechanisms appear to be involved, including the presence of tumour growth inducing inflammation and plasma CRP, as well as the tumours directly producing various inflammatory cytokines, including CRP, IL-6 and IL-8, which in turn induce hepatic CRP. Thus, CRP appears to be elevated both locally and systemically. It can thus be seen as a biomarker for the systemic bodily response to growing cancer, but also as a locally-acting mediator of inflammation-associated cancer growth and invasion. CRP has recently been included in a clinically useful prognostication schema (together with serum albumin levels) for GI cancers in general, including HCC, called the Glasgow Index \[[@R10]--[@R17],[@R19]--[@R21]\]. Other indices for systemic inflammation have recently been reported, especially PLR and NPR \[[@R22]--[@R28]\].

In this context, we addressed in this work the possible mechanisms that might underlie the prognostic usefulness of CRP, PLR and NLR. A working hypothesis that we have tested here, is that each or any of CRP, PLR or NLR might be related to indices of tumour aggressiveness, namely MTD, AFP, PVT and multifocality, as an explanation of their prognostic ability \[[@R30],[@R36],[@R37]\]. We found CRP was significantly related to MTD, AFP and PVT, and the Glasgow Index to MTD and AFP. Areas under ROC curves showed that the areas for PLR and CRP were statistically significant for high versus low MTD and for presence versus absence of PVT, and that CRP only was significant for high versus low AFP. However, the function, biological role and significance in determining HCC prognosis is still unclear. In the current study, we report only an association between plasma CRP levels or PLR ratio and indices of HCC aggressiveness.

These analyses suggest that the prognostic usefulness of the inflammatory markers PLR and CRP (but not NLR) may be due to their reflection of parameter values for tumour growth and invasiveness, but do not explain the mechanisms involved, nor do they address whether CRP and PLR are mechanistically involved in these parameters for tumour aggressiveness, or are just reactive reflections of these tumour behaviours.
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HCC

:   hepatocellular carcinoma

PVT

:   portal vein thrombosis
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:   alpha-fetoprotein
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:   maximum tumour diameter
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:   C-reactive protein

PLR

:   platelet lymphocyte ratio
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:   neutrophil lymphocyte ratio

CT

:   computerized axial tomography
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:   magnetic resonance imaging

![Results of the receiver operation characteristic (ROC) curve of PLR, NLR and CRP for (a) Maximum Tumor Diameter (MTD), (b) Alpha-fetoprotein (AFP), (c) Multifocality, and (d) Portal Vein Thrombosis (PVT) groups](nihms980838f1){#F1}

###### 

Comparisons of the neutrophils-to-lymphocyte ratio (NLR), the platelet-to-lymphocyte ratio (PLR) and the C-reactive protein (CRP) level between HCC patients

  Variable        Group      Values      n             Mean±SD         Median (IQR)   Min-Max                                   p[a](#TFN2){ref-type="table-fn"}
  --------------- ---------- ----------- ------------- --------------- -------------- ----------------------------------------- ----------------------------------
  MTD             \<3        NLR         65            4.33±4.33       2.97 (3.82)    0.37--26.50                               0.216
  ≥3              339        4.58±4.77   3.39 (2.86)   0.77--46.67                                                              
  \<3             PLR        63          0.11±0.08     0.09 (0.08)     0.03--0.44     0.002[\*](#TFN3){ref-type="table-fn"}     
  ≥3              329        0.17±0.14   0.13 (0.14)   0.02--0.96                                                               
  \<3             CRP        59          8.03±15.96    2.08 (6.17)     0.10--81.80    0.001[\*](#TFN3){ref-type="table-fn"}     
  ≥3                         284         19.19±32.63   5.34 (22.18)    0.10--192.00                                             
  AFP             \<20       NLR         163           4.09±3.25       3.03 (2.96)    0.37--18.78                               0.101
  ≥20                        261         4.81±5.39     3.56 (2.90)     0.88--46.67                                              
  \<20            PLR        160         0.15±0.14     0.11 (0.11)     0.02--0.88     0.061                                     
  ≥20             253        0.16±0.13   0.13 (0.13)   0.02--0.96                                                               
  \<20            CRP        149         14.93±34.39   3.13 (10.20)    0.10--192.00   \<0.001[\*](#TFN3){ref-type="table-fn"}   
  ≥20                        215         20.97±32.41   8.02 (25.64)    0.10--256.00                                             
  Multifocality   Unifocal   NLR         240           4.69±4.79       3.48 (3.10)    0.77--46.67                               0.087
  Multifocal                 156         4.36±4.66     3.15 (3.03)     0.37--39.29                                              
  Unifocal        PLR        230         0.16±0.13     0.13 (0.13)     0.02--0.96     0.041[\*](#TFN3){ref-type="table-fn"}     
  Multifocal      154        0.14±0.13   0.10 (0.11)   0.02--0.88                                                               
  Unifocal        CRP        200         16.85±31.59   4.16 (14.95)    0.10--192.00   0.191                                     
  Multifocal                 137         18.35±28.91   5.46 (25.45)    0.10--179.00                                             
  PVT             −          NLR         283           4.68±5.03       3.32 (3.05)    0.37--46.67                               0.895
  \+                         135         4.21±3.89     3.47 (2.83)     0.68--33.86                                              
  −               PLR        275         0.15±0.13     0.11 (0.11)     0.02--0.96     0.034[\*](#TFN3){ref-type="table-fn"}     
  \+              131        0.17±0.13   0.14 (0.16)   0.02--0.63                                                               
  −               CRP        244         14.39±28.04   3.32 (13.00)    0.10--180.00   \<0.001[\*](#TFN3){ref-type="table-fn"}   
  \+                         110         28.13±41.83   10.70 (29.98)   0.10--256.00                                             

SD, Standard Deviation; IQR, Interquartile Range; Min, Minimum; Max, Maximum;

Wilcoxon rank-sum (Mann-Whitney) test;

p-value\<0.05 is significant

###### 

Regression models on single variables and final models: (A) Linear regression models of the platelet-to-lymphocyte ratio (PLR) on single variables. (B) Logistic regression models of C-reactive protein (CRP) (≤*10/\>10*) on single variables. (C) Logistic regression models of Glasgow index (\<*2/=2*) on single variables. (D) Logistic regression model of CRP (≤*10/\>10*) on final model. (E) Logistic regression model of Glasgow index (\<*2/=2*) on final model

                                             Models on single variables                                                                                                                                                                                            
  ------------------------------------------ ---------------------------- ------- --------------------------------------- ----------------- --------- ----------------------------------------- ---------------- ------- ----------------------------------------- ----------------
  MTD (\<3/≥3)                               0.052                        0.018   0.004[\*](#TFN6){ref-type="table-fn"}   0.017 to 0.088    3.144     0.002[\*](#TFN6){ref-type="table-fn"}     1.529 to 6.463   2.957   0.007[\*](#TFN6){ref-type="table-fn"}     1.347 to 6.491
  AFP (\<20/≥20)                             0.013                        0.013   0.329                                   −0.013 to 0.039   2.269     \<0.001[\*](#TFN6){ref-type="table-fn"}   1.438 to 3.582   2.404   \<0.001[\*](#TFN6){ref-type="table-fn"}   1.471 to 3.929
  Multifocality (Unifocal/Multifocal)        −0.019                       0.014   0.173                                   −0.046 to 0.008   1.436     0.116                                     0.914 to 2.255   1.878   0.009[\*](#TFN6){ref-type="table-fn"}     1.168 to 3.019
  PVT (−/+)                                  0.022                        0.014   0.111                                   −0.005 to 0.050   2.211     0.001[\*](#TFN6){ref-type="table-fn"}     1.393 to 3.507   2.032   0.004[\*](#TFN6){ref-type="table-fn"}     1.261 to 3.274
                                             **Final Model**                                                                                                                                                                                                       
                                                                                                                                            **(D)**   **(E)**                                                                                                      
  Parameter[1](#TFN5){ref-type="table-fn"}                                                                                                  OR        p                                         95% C.I.         OR      p                                         95% C.I.
  MTD (\<3/≥3)                                                                                                                              2.860     0.007[\*](#TFN6){ref-type="table-fn"}     1.328 to 6.160   2.674   0.024[\*](#TFN6){ref-type="table-fn"}     1.142 to 6.261
  AFP (\<20/≥20)                                                                                                                            1.725     0.030[\*](#TFN6){ref-type="table-fn"}     1.053 to 2.826   1.765   0.039[\*](#TFN6){ref-type="table-fn"}     1.030 to 3.026
  Multifocality (Unifocal/Multifocal)                                                                                                       \-        \-                                        \-               1.563   0.084                                     0.942 to 2.595
  PVT (−/+)                                                                                                                                 1.785     0.024[\*](#TFN6){ref-type="table-fn"}     1.080 to 2.949   1.620   0.081                                     0.942 to 2.788

β: coefficient; se(β): standard error of coefficient; OR, Odds-Ratio; C.I.: confidence interval; AFP, Alpha-fetoprotein; MTD, Maximum Tumor Diameter; PVT, Portal Vein Thrombosis.

All multiple logistic regression final models were executed on all these variables, included together in the model, and selected with backward stepwise method

p-value\<0.05 is significant

###### 

Final models of logistic regression analysis for (A) Maximum Tumor Diameter (MTD), (B) Alpha-fetoprotein (AFP), (C) Multifocality and (D) Portal Vein Thrombosis (PVT) groups

                       \(A\)    \(B\)                                   \(C\)              \(D\)                                                                                                                                                                                 
  -------------------- -------- --------------------------------------- ------------------ ------- ----------------------------------------- ---------------- ------- --------------------------------------- ---------------- ------- ----------------------------------------- -----------------
  PLR                  26.338   0.046[\*](#TFN8){ref-type="table-fn"}   1.056 to 657.005   \-      \-                                        \-               \-      \-                                      \-               \-      \-                                        \-
  NLR                  \-       \-                                      \-                 \-      \-                                        \-               \-      \-                                      \-               0.947   0.094                                     0.888 to 1.009
  CRP (\>10)           2.662    0.009[\*](#TFN8){ref-type="table-fn"}   1.279 to 5.543     2.329   \<0.001[\*](#TFN8){ref-type="table-fn"}   1.470 to 3.689   1.466   0.098                                   0.932 to 2.306   2.301   \<0.001[\*](#TFN8){ref-type="table-fn"}   1.441 to 5.674
  PLR                  33.128   0.034[\*](#TFN8){ref-type="table-fn"}   1.304 to 841.785   \-      \-                                        \-               \-      \-                                      \-               5.083   0.073                                     0.860 to 30.038
  NLR                  \-       \-                                      \-                 \-      \-                                        \-               \-      \-                                      \-               0.932   0.046[\*](#TFN8){ref-type="table-fn"}     0.869 to 0.999
  Glasgow index (=2)   2.562    0.021[\*](#TFN8){ref-type="table-fn"}   1.155 to 5.683     2.381   0.001[\*](#TFN8){ref-type="table-fn"}     1.456 to 3.895   1.875   0.010[\*](#TFN8){ref-type="table-fn"}   1.165 to 3.017   1.945   0.008[\*](#TFN8){ref-type="table-fn"}     1.192 to 3.175

OR, Odds-Ratio; C.I.: confidence interval; AFP, Alpha-fetoprotein; MTD, Maximum Tumor Diameter; PVT, Portal Vein Thrombosis.

p-value\<0.05 is significant.

All multiple logistic regression final models were executed on all these variables, included together in the model, and selected with backward stepwise method

###### 

Results of the area under the receiver operating characteristic (ROC) curve with 95% confidence intervals of PLR, NLR and CRP for Maximum Tumor Diameter (MTD), Alpha-fetoprotein (AFP), Multifocality and Portal Vein Thrombosis (PVT) groups

                                        Parameter   Area under curve   Standard error                             P value                                  95% C.I.
  ------------------------------------- ----------- ------------------ ------------------------------------------ ---------------------------------------- --------------
  MTD (\<3/≥3)                          PLR         0.607              0.038                                      0.010[\*](#TFN11){ref-type="table-fn"}   0.533--0.682
  NLR                                   0.523       0.044              0.575                                      0.436--0.610                             
  CRP                                   0.642       0.038              0.001[\*](#TFN11){ref-type="table-fn"}     0.566--0.717                             
  AFP (\<20/≥20)                        PLR         0.551              0.031                                      0.102                                    0.490--0.611
  NLR                                   0.544       0.031              0.155                                      0.483--0.606                             
  CRP                                   0.635       0.030              \<0.001[\*](#TFN11){ref-type="table-fn"}   0.577--0.694                             
  Multifocality (unifocal/multifocal)   PLR         0.555              0.032                                      0.088                                    0.492--0.618
  NLR                                   0.561       0.033              0.057                                      0.498--0.625                             
  CRP                                   0.456       0.032              0.168                                      0.393--0.519                             
  PVT (+/−)                             PLR         0.575              0.034                                      0.024[\*](#TFN11){ref-type="table-fn"}   0.509--0.641
  NLR                                   0.498       0.032              0.960                                      0.435--0.562                             
  CRP                                   0.660       0.030              \<0.001[\*](#TFN11){ref-type="table-fn"}   0.600--0.719                             

C.I.: confidence interval.

p-value\<0.05 is significant

[^1]: These 3 authors contributed equally.
